Aveanna CEO sells 90K shares at $11.50 in offering

Aveanna Healthcare Holdings, Inc. (AVAH) reported that Chief Executive Officer Jeff Shaner sold 90,000 shares of common stock on August 20, 2026 at $11.50 per share, as part of an underwritten secondary offering of 15,000,000 shares.

Rhea-AI Filing Summary

Aveanna Healthcare Holdings, Inc. (AVAH) reported that Chief Executive Officer Jeff Shaner sold 90,000 shares of common stock on August 20, 2026 at $11.50 per share, as part of an underwritten secondary offering of 15,000,000 shares. Following this sale, he directly holds 2,561,972 shares, which include 1,080 shares acquired under the company’s Employee Stock Purchase Plan in June 2026.

Insider Trade Summary

Net Seller: 90,000 shares

Net Sell 1 txn

Insider Shaner Jeff

Role Chief Executive Officer

Sold 90,000 shs ($1.03M)

Type	Security	Shares	Price	Value
Sale	Common Stock, par value $0.01 per share F1, F2	90,000	$11.50	$1.03M

Holdings After Transaction: Common Stock, par value $0.01 per share — 2,561,972 shares (Direct)

Footnotes (2)

1. F1. Shares sold by the reporting person were part of an undewritten secondary offering of 15,000,000 shares of the Issuer's common stock which closed on August 24, 2026.
2. F2. Includes 1,080 shares acquired under the Registrant's Employee Stock Purchase Plan (the "ESPP") in June 2026.

Key Figures

Shares sold: 90,000 shares Sale price per share: $11.50 per share Shares held after transaction: 2,561,972 shares +2 more

5 metrics

Shares sold 90,000 shares Common Stock sold by CEO Jeff Shaner on August 20, 2026

Sale price per share $11.50 per share Price for the 90,000-share sale on August 20, 2026

Shares held after transaction 2,561,972 shares Direct holdings of CEO Jeff Shaner following the sale

Secondary offering size 15,000,000 shares Underwritten secondary offering of issuer’s common stock

ESPP shares included 1,080 shares Shares acquired under the Employee Stock Purchase Plan in June 2026

Key Terms

undewritten secondary offering, secondary offering, Employee Stock Purchase Plan

3 terms

undewritten secondary offering financial

"part of an undewritten secondary offering of 15,000,000 shares"

secondary offering financial

"part of an undewritten secondary offering of 15,000,000 shares"

A secondary offering is when a company sells new shares of its stock to the public after its initial sale. This allows existing shareholders or the company itself to raise additional money. For investors, it can impact the stock’s price by increasing the total number of shares available, which may influence the stock’s value and how the market perceives the company’s financial health.

Employee Stock Purchase Plan financial

"acquired under the Registrant's Employee Stock Purchase Plan (the "ESPP")"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AVAH disclose for CEO Jeff Shaner?

AVAH disclosed that CEO Jeff Shaner sold 90,000 shares of common stock on August 20, 2026 in a sale coded “S,” described as a sale in an open market or private transaction, at a reported price of $11.50 per share.

At what price did the AVAH CEO sell shares in this Form 4 filing?

The CEO’s reported sale of Aveanna Healthcare (AVAH) common stock was executed at $11.50 per share for 90,000 shares, according to the Form 4 transaction data and related footnote.

How many AVAH shares does the CEO hold after the reported sale?

After the reported sale, CEO Jeff Shaner directly holds 2,561,972 shares of Aveanna Healthcare (AVAH) common stock. This total includes 1,080 shares acquired under the company’s Employee Stock Purchase Plan in June 2026.

Was the AVAH CEO’s sale part of a larger secondary offering?

Yes. The 90,000 shares sold by the CEO were part of an underwritten secondary offering of 15,000,000 shares of Aveanna Healthcare common stock, which closed on August 24, 2026, as described in the transaction footnote.

What role did the Employee Stock Purchase Plan play in the CEO’s AVAH holdings?

The CEO’s post-transaction holdings of 2,561,972 AVAH shares include 1,080 shares acquired in June 2026 under the company’s Employee Stock Purchase Plan (ESPP), as noted in a Form 4 footnote.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 04:31 PM EDT Accepted by SEC EDGAR 08/24/2026 - 04:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shaner Jeff

(Last) (First) (Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA GEORGIA 30339

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	08/20/2026		S		90,000(1)	D	$11.5	2,561,972(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold by the reporting person were part of an undewritten secondary offering of 15,000,000 shares of the Issuer's common stock which closed on August 24, 2026.

2. Includes 1,080 shares acquired under the Registrant's Employee Stock Purchase Plan (the "ESPP") in June 2026.

	/s/ Jonathan Beckler, Attorney-in-Fact	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)